These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37276134)

  • 1. Measurement precision across cognitive domains in the Alzheimer's Disease Neuroimaging Initiative (ADNI) data set.
    Crane PK; Choi SE; Lee M; Scollard P; Sanders RE; Klinedinst B; Nakano C; Trittschuh EH; Mez J; Saykin AJ; Gibbons LE; Wang C; Mungas D; Zhu R; Foldi NS; Lamar M; Jutten R; Sikkes SAM; Grandoit E; Rabin LA; Jones RN; Tommet D; Mukherjee S
    Neuropsychology; 2023 May; 37(4):373-382. PubMed ID: 37276134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Voxel and surface-based topography of memory and executive deficits in mild cognitive impairment and Alzheimer's disease.
    Nho K; Risacher SL; Crane PK; DeCarli C; Glymour MM; Habeck C; Kim S; Lee GJ; Mormino E; Mukherjee S; Shen L; West JD; Saykin AJ;
    Brain Imaging Behav; 2012 Dec; 6(4):551-67. PubMed ID: 23070747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive reserve and clinical progression in Alzheimer disease: A paradoxical relationship.
    van Loenhoud AC; van der Flier WM; Wink AM; Dicks E; Groot C; Twisk J; Barkhof F; Scheltens P; Ossenkoppele R;
    Neurology; 2019 Jul; 93(4):e334-e346. PubMed ID: 31266904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of analgesics on executive function and memory in the Alzheimer's Disease Neuroimaging Initiative Database.
    Doan L; Choi D; Kline R;
    Scand J Pain; 2017 Oct; 17():408-417. PubMed ID: 29103867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropsychological Equivalence of the Clinical Diagnosis of Mild Cognitive Impairment in the National Alzheimer's Coordinating Center Uniform Data Set and Alzheimer's Disease Neuroimaging Initiative.
    Kiselica AM; Benge JF;
    Dement Geriatr Cogn Disord; 2021; 50(3):231-236. PubMed ID: 34186536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor analyses of the ADNI neuropsychological battery: An examination of diagnostic and longitudinal invariance.
    Chang M; Brainerd CJ
    Neuropsychology; 2021 May; 35(4):434-450. PubMed ID: 34043393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive domain harmonization and cocalibration in studies of older adults.
    Mukherjee S; Choi SE; Lee ML; Scollard P; Trittschuh EH; Mez J; Saykin AJ; Gibbons LE; Sanders RE; Zaman AF; Teylan MA; Kukull WA; Barnes LL; Bennett DA; Lacroix AZ; Larson EB; Cuccaro M; Mercado S; Dumitrescu L; Hohman TJ; Crane PK
    Neuropsychology; 2023 May; 37(4):409-423. PubMed ID: 35925737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of circulating saturated long-chain fatty acids with risk of mild cognitive impairment and Alzheimer's disease in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort.
    Fan L; Borenstein AR; Wang S; Nho K; Zhu X; Wen W; Huang X; Mortimer JA; Shrubsole MJ; Dai Q;
    EBioMedicine; 2023 Nov; 97():104818. PubMed ID: 37793213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. White matter hyperintensities and cognition across different Alzheimer's biomarker profiles.
    Lam S; Lipton RB; Harvey DJ; Zammit AR; Ezzati A;
    J Am Geriatr Soc; 2021 Jul; 69(7):1906-1915. PubMed ID: 33891712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lower Serum Calcium as a Potentially Associated Factor for Conversion of Mild Cognitive Impairment to Early Alzheimer's Disease in the Japanese Alzheimer's Disease Neuroimaging Initiative.
    Sato K; Mano T; Ihara R; Suzuki K; Tomita N; Arai H; Ishii K; Senda M; Ito K; Ikeuchi T; Kuwano R; Matsuda H; Iwatsubo T; Toda T; Iwata A;
    J Alzheimers Dis; 2019; 68(2):777-788. PubMed ID: 30814351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of language and visuospatial composite scores in ADNI.
    Choi SE; Mukherjee S; Gibbons LE; Sanders RE; Jones RN; Tommet D; Mez J; Trittschuh EH; Saykin A; Lamar M; Rabin L; Foldi NS; Sikkes S; Jutten RJ; Grandoit E; Mac Donald C; Risacher S; Groot C; Ossenkoppele R; ; Crane PK
    Alzheimers Dement (N Y); 2020; 6(1):e12072. PubMed ID: 33313380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ¹⁸F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
    Smailagic N; Vacante M; Hyde C; Martin S; Ukoumunne O; Sachpekidis C
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD010632. PubMed ID: 25629415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal trajectory effects of different MCI subtypes on general cognitive and daily functions in a population-based cohort of older adults.
    Yuan M; Long X; Zhang Z; Rong M; Lian S; Peng Y; Fang Y;
    J Psychiatr Res; 2024 Mar; 171():296-305. PubMed ID: 38335640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modelling prognostic trajectories of cognitive decline due to Alzheimer's disease.
    Giorgio J; Landau SM; Jagust WJ; Tino P; Kourtzi Z;
    Neuroimage Clin; 2020; 26():102199. PubMed ID: 32106025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal Trajectories of Informant-Reported Daily Functioning in Empirically Defined Subtypes of Mild Cognitive Impairment.
    Thomas KR; Edmonds EC; Delano-Wood L; Bondi MW
    J Int Neuropsychol Soc; 2017 Jul; 23(6):521-527. PubMed ID: 28487004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between composite scores of domain-specific cognitive functions and regional patterns of atrophy and functional connectivity in the Alzheimer's disease spectrum.
    Amaefule CO; Dyrba M; Wolfsgruber S; Polcher A; Schneider A; Fliessbach K; Spottke A; Meiberth D; Preis L; Peters O; Incesoy EI; Spruth EJ; Priller J; Altenstein S; Bartels C; Wiltfang J; Janowitz D; Bürger K; Laske C; Munk M; Rudolph J; Glanz W; Dobisch L; Haynes JD; Dechent P; Ertl-Wagner B; Scheffler K; Kilimann I; Düzel E; Metzger CD; Wagner M; Jessen F; Teipel SJ
    Neuroimage Clin; 2021; 29():102533. PubMed ID: 33360018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Harnessing forgetfulness: can episodic-memory tests predict early Alzheimer's disease?
    Warren SL; Moustafa AA; Alashwal H;
    Exp Brain Res; 2021 Sep; 239(9):2925-2937. PubMed ID: 34313791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combining tau-PET and fMRI meta-analyses for patient-centered prediction of cognitive decline in Alzheimer's disease.
    Biel D; Luan Y; Brendel M; Hager P; Dewenter A; Moscoso A; Otero Svaldi D; Higgins IA; Pontecorvo M; Römer S; Steward A; Rubinski A; Zheng L; Schöll M; Shcherbinin S; Ewers M; Franzmeier N;
    Alzheimers Res Ther; 2022 Nov; 14(1):166. PubMed ID: 36345046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Random forest feature selection, fusion and ensemble strategy: Combining multiple morphological MRI measures to discriminate among healhy elderly, MCI, cMCI and alzheimer's disease patients: From the alzheimer's disease neuroimaging initiative (ADNI) database.
    Dimitriadis SI; Liparas D; Tsolaki MN;
    J Neurosci Methods; 2018 May; 302():14-23. PubMed ID: 29269320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and assessment of a composite score for memory in the Alzheimer's Disease Neuroimaging Initiative (ADNI).
    Crane PK; Carle A; Gibbons LE; Insel P; Mackin RS; Gross A; Jones RN; Mukherjee S; Curtis SM; Harvey D; Weiner M; Mungas D;
    Brain Imaging Behav; 2012 Dec; 6(4):502-16. PubMed ID: 22782295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.